FLOT2 and non-small cell lung carcinoma: Therefore, our results suggest an important interaction between Flot-2 and EGFR intracellular pathway in the progression of NSCLC and high expression of Flot-2 and EGFR proteins might have a positive synergistic effect on patients’ outcome.